GeoVax Labs, Inc. (NASDAQ:GOVXW – Get Free Report) shares dropped 14.1% during trading on Wednesday . The stock traded as low as $0.10 and last traded at $0.10. Approximately 19,999 shares changed hands during trading, a decline of 8% from the average daily volume of 21,681 shares. The stock had previously closed at $0.12.
GeoVax Labs Stock Performance
The firm has a 50 day simple moving average of $0.12 and a two-hundred day simple moving average of $0.15.
GeoVax Labs Company Profile
GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers.
Featured Articles
- Five stocks we like better than GeoVax Labs
- Quiet Period Expirations Explained
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Best Stocks Under $10.00
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- What Do S&P 500 Stocks Tell Investors About the Market?
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for GeoVax Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeoVax Labs and related companies with MarketBeat.com's FREE daily email newsletter.
